Taprizosin(UK-338003) is a selective and orally active alpha1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
Molecular Weight:
506.58
Purity:
99.11%
CAS Number:
[210538-44-6]
Formula:
C25H26N6O4S
Target:
Adrenergic Receptor
T28922
* VAT and and shipping costs not included. Errors and price changes excepted